|
|
|
 Innovative Solutions for Diastolic Heart Failure Over 5 million people in the US and 25 million people worldwide suffer from heart failure. Over 30% of these patients suffer from diastolic heart failure (DHF) and are without effective treatment. CorAssist is developing the first device focused on treating diastolic heart failure patients. CorAssist is committed to developing innovative therapeutic products for treating diastolic heart failure. The company's first product, the ImCardia™ is the first device to directly improve cardiac diastolic function. |
 |
ImCardia™ The company's first product, the ImCardia™, is the first device to directly improve cardiac diastolic function. Read more.. ImCardia MIS The ImCardia MIS is a second generation, minimally invasive version of the ImCardia device. It will allow for smaller incisions and less trauma to the patient. Read more.. Aurora The Aurora is an elastic device placed inside the LV through a minimally invasive or percutaneous procedure. The device applies direct expansion forces on the LV wall and the septum. Read more.. |
||||||||||||||||||||||||||
 |
 |
 |